Critical care management of chimeric antigen receptor T‐cell therapy recipients-Reference-Cited by-同舟云学术

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Published:2021-10-06 Issue:1 Volume:72 Page:78-93
ISSN:0007-9235
Container-title:CA: A Cancer Journal for Clinicians
language:en
Short-container-title:CA A Cancer J Clinicians

Author:

Shimabukuro‐Vornhagen Alexander¹²^ORCID,Böll Boris¹²,Schellongowski Peter²³,Valade Sandrine⁴,Metaxa Victoria⁵,Azoulay Elie⁴,Bergwelt‐Baildon Michael²⁶⁷⁸⁹

Affiliation:

1. Department I of Internal Medicine University of Cologne, Faculty of Medicine and University Hospital Cologne Cologne Germany

2. Intensive Care in Hematologic and Oncologic Patients (iCHOP) Cologne Germany

3. Department of Medicine I Intensive Care Unit 13i2, Comprehensive Cancer Center Center of Excellence in Medical Intensive Care (CEMIC) Medical University of Vienna Vienna Austria

4. Medical Intensive Care Unit St Louis Teaching HospitalPublic Assistance Hospitals of Paris Paris France

5. Department of Critical Care King's College Hospital National Health Service Foundation Trust London United Kingdom

6. Department of Medicine III University HospitalLudwig‐Maximilians University Munich Munich Germany

7. Munich Comprehensive Cancer Center University HospitalLudwig‐Maximilians University Munich Munich Germany

8. Bavarian Center for Cancer Research Munich Germany

9. Nine‐i Multinational Research Network, Service de Médecine Intensive et Réanimaton Médicale, Hôpital Saint‐Louis France

Publisher

Wiley

Subject

Oncology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21702

Reference121 articles.

1. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

2. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

3. CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

4. Gene transfer in humans using a conditionally replicating lentiviral vector

5. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research hotspots and trend of glioblastoma immunotherapy: a bibliometric and visual analysis;Frontiers in Oncology;2024-08-07

2. Nephrotoxicity in Bispecific Antibodies Recipients: Focus on T-Cell-Engaging Bispecific Antibodies;OncoTargets and Therapy;2024-07

3. CAR-T cell therapy in advanced thyroid cancer: from basic to clinical;Frontiers in Immunology;2024-06-07

4. A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy;Molecular Cancer;2024-06-01

5. CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors;Med;2024-06